A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors (Q37539213)
Jump to navigation
Jump to search
scientific article published on 03 December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors |
scientific article published on 03 December 2013 |
Statements
1 reference
A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors (English)
1 reference
Anthony W Tolcher
1 reference
Wendi V Rodrigueza
1 reference
Drew W Rasco
1 reference
Amita Patnaik
1 reference
Kyriakos P Papadopoulos
1 reference
Alex Amaya
1 reference
Timothy D Moore
1 reference
Shari K Gaylor
1 reference
Charles L Bisgaier
1 reference
Mina P Sooch
1 reference
Michael J Woolliscroft
1 reference
Richard A Messmann
1 reference
1 reference
3 December 2013
1 reference
1 reference
Identifiers
1 reference